Log In
BCIQ
Print this Print this
 

Alpha-1 antitrypsin (AAT) (A1AT) (SERPINA1)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Alpha-1 antitrypsin (AAT) (A1AT) (SERPINA1)

BCIQ
Print ChartPrint this
Marketed, 2 Marketed, 4 Phase II/III, 3 Phase II, 2 Phase I/II, 1 Phase I/II, 1 Phase I/II, 1 Phase I, 1 Phase I, 1 Preclinical, 5 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase II/IIIMarketed
Endocrine / Metabolic

1

1

1

-

3

4

Hepatic

-

1

1

-

-

-

Pulmonary

5

-

-

2

-

2

Transplant

-

-

1

-

-

-




 Products Targeting Alpha-1 antitrypsin (AAT) (A1AT) (SERPINA1)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

7

$33,560.0M

$12,694.9M

$85.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today